Get Enquiry

Dihydropyridine Calcium Channel Blockers

Category Details :

A class of drugs known as dihydropyridine calcium channel blockers, or DHP CCBs, is mostly prescribed to treat disorders including hypertension, or high blood pressure, and specific forms of angina, or chest discomfort. These medications function by obstructing the calcium channels in the heart and blood vessels, which relaxes the arteries and reduces the workload on the heart. This is a quick synopsis of DHP CCBs: Mechanism of Action: In cardiac muscle cells and vascular smooth muscle, DHP CCBs mostly affect L-type calcium channels. These channels are inhibited, which stops calcium from entering the cells and causes the heart's contractility to diminish and the smooth muscle in the arteries to vasodilate.Pharmacokinetics: Amlodipine, nifedipine, and felodipine are often prescribed DHP CCBs. They have a strong bioavailability and are typically used orally. These medications are extensively metabolized in the liver, mostly via the CYP3A4 enzyme system, and their byproducts are eliminated in the urine. Applications in Clinical Practice: Hypertension: As first-line treatments for hypertension, DHP CCBs are frequently employed. Blood pressure is lowered as a result of their vasodilatory actions, which lower peripheral vascular resistance. For example, amlodipine is a drug that is often recommended once daily to treat hypertension. Angina Pectoris: DHP CCBs aid in coronary artery dilation, which increases the heart muscle's oxygen supply, in the treatment of angina. This can lessen angina-related chest pain sensations. This is a common usage for nifedipine, especially in extended-release forms.Adverse Effects: Although DHP CCBs are usually well tolerated, they can have the following negative effects: Ankle and foot swelling is known as peripheral edema. Floshing Headache lightheadedness Heart palpitations Constipation (more frequent when using the non-DHP CCB verapamil) gingival hyperplasia, particularly in response to nifedipine Contraindications: Because DHP CCBs lower blood pressure, people with hypotension (low blood pressure) should use them with caution. Additionally, individuals with a history of medication allergy and those with severe aortic stenosis should not use them.Drug Interactions: Because DHP CCBs are metabolized by the CYP3A4 enzyme system, their levels in the body may be impacted by their concurrent usage with potent inducers or inhibitors of this system, such as rifampin or St. John's Wort, or ketoconazole and clarithromycin. When using these medications with other prescriptions, it's critical to keep an eye out for any possible interactions. To sum up, dihydropyridine calcium channel blockers, which lower peripheral vascular resistance and raise coronary blood flow, are effective drugs for treating angina and hypertension. Despite their effectiveness, they should be used with caution in some patient populations because of possible interactions and negative effects.